acadia mercer street LLC

111 eighth avenue
13th floor
new york, new york 10011

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 31, 2013

NYS DOS ID#
4353902

County
WESTCHESTER

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2013 - ACADIA MERCER STREET LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Ex-employee dismisses suit against hedge fund co-CEO
    By Carleton English - Thursday Jul 6, 2017

    Robert Mercer, co-CEO of hedge fund Renaissance Technologies, narrowly avoided a legal headache. Former Ren Tech employee David Magerman voluntarily dismissed his wrongful termination suit against Mercer, according to court documents filed late Wednesday. Mercer’s response to the case was due Friday. There was no settlement in the case, a source told The Post. Magerman,...

    Source: New York Post: Business
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study
    By Ben Fidler - Wednesday Nov 15, 2017

    Acorda Therapeutics’ rebuilding plan just suffered another setback, leaving the fate of one of the experimental Parkinson’s disease drugs that is closest to market unclear. Ardsley, NY-based Acorda (NASDAQ: ACOR) said Wednesday morning that it has seen troubling safety problems in a Phase 3 trial of its experimental Parkinson’s disease drug tozadenant. Acorda reported cases […]

    Source: Xconomy New York
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York